Home
  • E-mailSverre.Sandberg@uib.no
  • Phone+47 55 58 67 06
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2020). The European Biological Variation Study (EuBIVAS): Weekly biological variation of cardiac troponin i estimated by the use of two different high-sensitivity cardiac troponin i assays. Clinical Chemistry and Laboratory Medicine. 1741-1747.
  • Show author(s) (2020). Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study. Orphanet Journal of Rare Diseases. 1-11.
  • Show author(s) (2020). Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clinical Biochemistry. 18-22.
  • Show author(s) (2020). Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Clinical Chemistry and Laboratory Medicine. 588-596.
  • Show author(s) (2020). Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. European Journal of Clinical Microbiology and Infectious Diseases. 549-558.
  • Show author(s) (2020). Health-related quality of life in porphyria cutanea tarda: A cross-sectional registry based study. Health and Quality of Life Outcomes. 1-9.
  • Show author(s) (2020). Analytical performance specifications for lipoprotein(a), apolipoprotein B-100, and apolipoprotein A-I using the biological variation model in the EuBIVAS population. Clinical Chemistry. 727-736.
  • Show author(s) (2019). The importance of the Biological Variation Data Critical Appraisal Checklist when designing experimental studies on biological variation. Comparison of two papers reporting biological variation results for S100-β and neuron-specific enolase proteins. Biochimica Clinica. 59-66.
  • Show author(s) (2019). Self-efficacy and self-management strategies in acute intermittent porphyria. BMC Health Services Research.
  • Show author(s) (2019). Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway. Diabetic Medicine. 1-10.
  • Show author(s) (2019). Concentration of fibrin monomer in pregnancy and during the postpartum period. Annals of Clinical Biochemistry. 1-9.
  • Show author(s) (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy.
  • Show author(s) (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. Clinical Chemistry and Laboratory Medicine. 1-12.
  • Show author(s) (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. Clinical Chemistry and Laboratory Medicine. 1309-1318.
  • Show author(s) (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clinical Chemistry. 1380-1393.
  • Show author(s) (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes ? A feasibility study. PLOS ONE. 1-13.
  • Show author(s) (2018). Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. Journal of Internal Medicine. 78-91.
  • Show author(s) (2018). Quality control of Norwegian pharmacy HbA1c testing: a modest beginning. Journal of Diabetes Science and Technology. 753-761.
  • Show author(s) (2018). Population, general practitioner and practice characteristics are associated with screening procedures for microvascular complications in Type 2 diabetes care in Norway. Diabetic Medicine. 1-13.
  • Show author(s) (2018). Harmonization initiatives in the generation, reporting and application of biological variation data. Clinical Chemistry and Laboratory Medicine. 1629-1636.
  • Show author(s) (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. Clinical Chemistry and Laboratory Medicine. 106-114.
  • Show author(s) (2018). Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer. Clinica Chimica Acta. 185-191.
  • Show author(s) (2018). Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014. Scandinavian Journal of Primary Health Care. 170-179.
  • Show author(s) (2017). Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements? Scandinavian Journal of Primary Health Care. 299-306.
  • Show author(s) (2017). Type 2 diabetes in general practice in Norway 2005-2015: moderate improvements in risk factor control, but still major gaps in complication screening. BMJ Open Diabetes Research & Care. 11 pages.
  • Show author(s) (2017). The use of error and uncertainty methods in the medical laboratory. Clinical Chemistry and Laboratory Medicine. 209-219.
  • Show author(s) (2017). The biological variation data critical appraisal checklist: A standard for evaluating studies on biological variation. Clinical Chemistry. 501-514.
  • Show author(s) (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
  • Show author(s) (2017). Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference. Clinical Chemistry and Laboratory Medicine. 1849-1856.
  • Show author(s) (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine. 1857-1864.
  • Show author(s) (2017). Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clinical Chemistry and Laboratory Medicine. 489-500.
  • Show author(s) (2017). Glycemic control and complications in patients with type 1 diabetes – a registry-based longitudinal study of adolescents and young adults. Pediatric Diabetes. 188-195.
  • Show author(s) (2017). Estimates of within-subject biological variation of protein c, antithrombin, protein s free, protein s activity, and activated protein c resistance in pregnant women. Clinical Chemistry. 898-907.
  • Show author(s) (2017). Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect. Clinica Chimica Acta. 166-173.
  • Show author(s) (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clinical Chemistry. 1141-1150.
  • Show author(s) (2017). Acute hepatic porphyria and cancer risk: a nationwide cohort study. Journal of Internal Medicine. 229-240.
  • Show author(s) (2017). A pragmatic approach to sample acceptance and rejection. Clinical Biochemistry. 605-611.
  • Show author(s) (2016). The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. Scandinavian Journal of Clinical and Laboratory Investigation. 645-652.
  • Show author(s) (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
  • Show author(s) (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
  • Show author(s) (2016). Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thrombosis Research. 1-7.
  • Show author(s) (2016). Illness perception and psychological distress in persons with porphyria cutanea tarda. Acta Dermato-Venereologica. 674-678.
  • Show author(s) (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
  • Show author(s) (2016). Biological variation: The effect of different distributions on estimated within-person variation and reference change values. Clinical Chemistry. 725-736.
  • Show author(s) (2015). Proposal for the modification of the conventional model for establishing performance specifications. Clinical Chemistry and Laboratory Medicine. 925-937.
  • Show author(s) (2015). Point-of-care urine albumin in general practice offices: Effect of participation in an external quality assurance scheme. Clinical Chemistry and Laboratory Medicine. 45-51.
  • Show author(s) (2015). Feasibility of using self-reported patient data in a national diabetes register. BMC Health Services Research. 1-7.
  • Show author(s) (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter? Clinical Chemistry and Laboratory Medicine. 1433-1439.
  • Show author(s) (2015). Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. Clinical Chemistry and Laboratory Medicine. 857-862.
  • Show author(s) (2015). An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. Clinical Chemistry and Laboratory Medicine. 1593-1603.
  • Show author(s) (2015). A checklist for critical appraisal of studies of biological variation. Clinical Chemistry and Laboratory Medicine. 879-885.
  • Show author(s) (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clinical Chemistry. 838-847.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2014). Porfyrisykdommer i Norge. Tidsskrift for Den norske legeforening. 831-835.
  • Show author(s) (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
  • Show author(s) (2014). How to achieve harmonisation of laboratory testing -The complete picture. Clinica Chimica Acta. 8-14.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). Albumin adsorption onto surfaces of urine collection and analysis containers. Clinica Chimica Acta. 40-45.
  • Show author(s) (2013). The incidence of inherited porphyrias in Europe. The Journal of Inherited Metabolic Disease (JIMD). 849-857.
  • Show author(s) (2013). The Norwegian Diabetes Register for Adults –an overview of the first years. Norsk Epidemiologi. 29-34.
  • Show author(s) (2013). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine. 229-241.
  • Show author(s) (2013). Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue. Annales de Biologie Clinique. 707-716.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
  • Show author(s) (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Bioscience Reports. 617-U203.
  • Show author(s) (2013). Behandlingen av type 1-diabetes i spesialisthelsetjenesten – data fra Norsk diabetesregister for voksne. Tidsskrift for Den norske legeforening. 2257-2261.
  • Show author(s) (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase. Clinical Chemistry and Laboratory Medicine. 1997-2007.
  • Show author(s) (2012). Regional differences in sales of glucometer strips and antidiabetics. Tidsskrift for Den norske legeforening. 1453-1456.
  • Show author(s) (2012). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2012). Interpretation and management of INR results: A case history based survey in 13 countries. Thrombosis Research. 309-315.
  • Show author(s) (2012). Increased yet iron-restricted erythropoiesis in postpartum mothers. Annals of Hematology. 1435-1441.
  • Show author(s) (2012). How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests? Scandinavian Journal of Clinical and Laboratory Investigation. 143-151.
  • Show author(s) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Show author(s) (2012). Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. Orphanet Journal of Rare Diseases. 9 pages.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2012). Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clinical Chemistry. 1306-1313.
  • Show author(s) (2012). A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. Annals of Clinical Biochemistry. 561-569.
  • Show author(s) (2011). Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clinical Chemistry and Laboratory Medicine. 1501-1507.
  • Show author(s) (2011). Quality assurance of laboratory work and clinical use of laboratory tests in general practice in Norway: A survey. Scandinavian Journal of Primary Health Care. 171-175.
  • Show author(s) (2011). Preanalytical quality improvement: from dream to reality. Clinical Chemistry and Laboratory Medicine. 1113-1126.
  • Show author(s) (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clinica Chimica Acta. 1138-1142.
  • Show author(s) (2011). Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study. The Journal of Inherited Metabolic Disease (JIMD). 217-223.
  • Show author(s) (2011). European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clinical Chemistry. 1514-1523.
  • Show author(s) (2011). Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. Diabetes Technology & Therapeutics. 883-892.
  • Show author(s) (2011). Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? Clinical Chemistry and Laboratory Medicine. 637-640.
  • Show author(s) (2010). Usefulness of factor V Leiden mutation testing in clinical practice. European Journal of Human Genetics. 862-866.
  • Show author(s) (2010). Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. Pharmacy Practice. 62-69.
  • Show author(s) (2010). Porfyri: Symptomer - diagnostisering - behandling. Bioingeniøren. 6-9.
  • Show author(s) (2010). Implementation of a method for glucose measurements in community pharmacies. International Journal of Pharmacy Practice (IJPP). 13-19.
  • Show author(s) (2010). Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care. Diabetes Research and Clinical Practice. 103-109.
  • Show author(s) (2008). Riktigere bruk av laboratorietjenester – økonomiske aspekter. Tidsskrift for Den norske legeforening. 814-817.
  • Show author(s) (2008). Riktigere bruk av laboratorietjenester – medisinske aspekter. Tidsskrift for Den norske legeforening. 810-813.
  • Show author(s) (2006). Quality assessment of urine dip-slides in primary care. Tidsskrift for Den norske legeforening. 149-152.
  • Show author(s) (2006). Proficiency testing in analytical chemistry, microbiology and laboratory medicine - working group discussions on current status, problems and future directions. Accreditation and Quality Assurance. 446-450.
  • Show author(s) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry.
  • Show author(s) (2006). Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry. 650-656.
  • Show author(s) (2005). Postanalytical external quality assessment of blood glucose and hemoglobin A(1c): An international survey. Clinical Chemistry. 1145-1153.
  • Show author(s) (2005). Between-lot variation in external quality assessment of glucose: Clinical importance and effect on participant performance evaluation. Clinical Chemistry. 1632-1636.
  • Show author(s) (2004). Urine analysis and decision-making on cystitis in general practice. Scandinavian Journal of Clinical and Laboratory Investigation. 729-736.
  • Show author(s) (2004). Prostrate-specific antigen and prostate cancer: General practitioners' and urologists' use of evidence-based information. Tidsskrift for Den norske legeforening. 2893-2895.
  • Show author(s) (2004). Evidence-based guidelines in laboratory medicine: Principles and methods. Clinical Chemistry. 806-818.
  • Show author(s) (2004). Basic model and preliminary results on a Nordfond project on measurements reported on an ordinal scale. Klinisk Biokemi i Norden. 21-26.
  • Show author(s) (2004). A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scandinavian Journal of Clinical and Laboratory Investigation. 385-398.
  • Show author(s) (2003). Human reticulocytes isolated from peripheral blood: maturation time and hemoglobin synthesis. Laboratory Hematology. 198-206.
  • Show author(s) (2003). Health technology assessment and implications for clinical practice: The case of prostate cancer screening. Scandinavian Journal of Clinical and Laboratory Investigation. 331-338.
  • Show author(s) (2003). Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. Disease Markers. 41-46.
  • Show author(s) (2003). Evaluering av nye laboratorieanalyser. Tidsskrift for Den norske legeforening. 337-339.
  • Show author(s) (2003). Evaluation of new laboratory tests. Tidsskrift for Den norske legeforening. 377-379.
  • Show author(s) (2003). Er GUM skadelig - eller blot overflødig? Klinisk Biokemi i Norden. 27-32.
  • Show author(s) (2002). Instruments for self-monitoring of blood-glucose: comparison of testing quality achieved by patients and a technician. Clinical Chemistry. 994-1003.
  • Show author(s) (2001). Quality of rapid tests for determination of infectious mononucleosis. Tidsskrift for Den norske legeforening. 1793-1797.
  • Show author(s) (2001). Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clinical Chemistry. 67-73.
  • Show author(s) (2001). Models for combining random and systematic errors, assumptions and consequences for different models. Clinical Chemistry and Laboratory Medicine. 589-595.
  • Show author(s) (2001). Interpretation of hemaglobin A(1c)(HbA(1c)) values among diabetic patients: implications for quality specifications for HbA(1c). Clinical Chemistry. 1212-1217.
  • Show author(s) (2001). Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clinical Chemistry and Laboratory Medicine. 160-165.
  • Show author(s) (2001). External quality assessment of general practice laboratories: organizational issues and interpretation of feedback reports. Scandinavian Journal of Clinical and Laboratory Investigation. 103-110.
  • Show author(s) (2001). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 3435-3436.
  • Show author(s) (2001). Akutt intermitterende porfyri er en vanskelig diagnose - spesielt hos barn. Tidsskrift for Den norske legeforening. 2822-2825.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 4437-4448.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Nodelling an estimation of measurement error. Statistics in Medicine. 146.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241 pages.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (1999). The index of individuality is often a misinterpreted quantity characteristic. Clinical Chemistry and Laboratory Medicine. 655-661.
  • Show author(s) (1999). Skandinavisk utprøving av laboratorieutstyr for primærhelsetjenesten. Etablering av SKUP og igangsetting av de første evalueringene. Klinisk Biokemi i Norden. 56-60.
  • Show author(s) (1999). Quality specifications based upon objective analyses based upon clinical needs. Scandinavian Journal of Clinical and Laboratory Investigation.
  • Show author(s) (1999). Oppslagsbok i laboratoriemedisin. Tidsskrift for Den norske legeforening.
  • Show author(s) (1999). Measurement error and laboratory medicine. Statistics in Medicine.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretations in general practice. A method for developing quality goals from clinicians' opinion and to implement guidelines. Labquality News. 13-14.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretation. Accreditation and Quality Assurance. 414-415.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Circadian variations in human peripheral blood on days with and witout bone marrow sampling and relation to bone marroe cell proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian variation in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian Variations in Human Peripheral Blood on Days With and Without Bone Marrow Sampling and Relation to Bone Marrow Cell Proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Bruk og tolking av serum-kalsiumanalyse. Tidsskrift for Den norske legeforening. 3299.
  • Show author(s) (1998). Resultater fra NOKLUS' utsendelser 1993-97. Tidsskrift for Den norske legeforening. 1196-1200.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviewing in laboratory medicine. JIFCC. 154-155.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5-5.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1996). Erythropoietic, protoporphyria: two populations of reticulocytes, with and without protoporphyrin. European Journal of Clinical Investigation. 270-8.
  • Show author(s) (1996). Analysekvalitet av hemoglobin og glukose i allmennpraksis. Tidsskrift for Den norske legeforening. 25-9.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationship between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-89.
Academic lecture
  • Show author(s) (2017). Type 2 diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk Control but still major gaps in complication screening.
  • Show author(s) (2007). Control of patients' glucometers and SMBG technique in community pharmacies.
  • Show author(s) (2006). How to deal with qualitative tests? Principles.
  • Show author(s) (2004). Hvordan bruker legene urinstrimmelen til diagnostikk av UVI?
Abstract
  • Show author(s) (2014). POC testing instruments for diagnosing and monitoring diabetes in clinical settings. Biochemia Medica. S39-S40.
  • Show author(s) (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. The FEBS Journal. 298-298.
  • Show author(s) (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in minors. British Journal of Dermatology. 1133-1134.
  • Show author(s) (2011). POST-ANALYTICAL EXTERNAL QUALITY ASSESSMENT - A WAY TO ASSESS TEST REQUESTING AND INTERPRETATION. Clinical Chemistry and Laboratory Medicine. S111-S111.
  • Show author(s) (2011). Optimizing porphyria diagnostics with emphasis on pre-analytical, analytical and postanalytical aspects S. Sandberg on behalf of EPNET. British Journal of Dermatology. 1129-1129.
  • Show author(s) (2010). Characterization of the molecular basis of acute intermittent porphyria. The FEBS Journal. 76-76.
  • Show author(s) (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. The Journal of Inherited Metabolic Disease (JIMD). S177-S177.
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
  • Show author(s) (2005). Can we interpret laboratory results correctly? Clinica Chimica Acta.
  • Show author(s) (2005). Between lot variation in external quality assessment of glucose: Clinical importance and effect on the evaluation of participants' performance. Clinica Chimica Acta.
Academic literature review
  • Show author(s) (2021). The European Biological Variation Study (EuBIVAS): A summary report. Clinical Chemistry and Laboratory Medicine. 1-13.
  • Show author(s) (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta. 407-414.
  • Show author(s) (2021). Biological variation of cardiac troponins in health and disease: A systematic review and meta-analysis. Clinical Chemistry. 256-264.
  • Show author(s) (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 pages.
  • Show author(s) (2020). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. Clinical Chemistry and Laboratory Medicine. 1-10.
  • Show author(s) (2019). Systematic review of the biological variation data for diabetes related analytes. Clinica Chimica Acta. 61-67.
  • Show author(s) (2019). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. Clinical Chemistry and Laboratory Medicine. 25-32.
  • Show author(s) (2019). Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clinica Chimica Acta. 467-475.
  • Show author(s) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Show author(s) (2017). Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clinical Chemistry and Laboratory Medicine. 189-194.
  • Show author(s) (2014). How to conduct External Quality Assessment Schemes for the pre-analytical phase? Biochemia Medica. 114-122.
  • Show author(s) (2013). Glucose meters - fit for clinical purpose. Clinical Chemistry and Laboratory Medicine. 943-952.
  • Show author(s) (2012). Self-monitoring of blood glucose in patients with diabetes who do not use insulinuare guidelines evidence-based? Diabetic Medicine. 1226-1236.
  • Show author(s) (2010). Self-monitoring of blood glucose with a focus on analytical quality: an overview. Clinical Chemistry and Laboratory Medicine. 963-972.
  • Show author(s) (2009). Evaluation of prescription and interpretation of microalbuminuria by general practitioners. Annales de Biologie Clinique. 47-53.
  • Show author(s) (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clinical Chemistry. 24-38.

More information in national current research information system (CRIStin)